Credit Suisse’s Fulgent Genetics FLGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $677K | Buy |
31,209
+865
| +3% | +$18.8K | ﹤0.01% | 2485 |
|
|
2023
Q4 | $877K | Buy |
30,344
+6,121
| +25% | +$177K | ﹤0.01% | 2409 |
|
|
2023
Q3 | $648K | Sell |
24,223
-1,479
| -6% | -$39.5K | ﹤0.01% | 2535 |
|
|
2023
Q2 | $952K | Sell |
25,702
-1,792
| -7% | -$66.4K | ﹤0.01% | 2397 |
|
|
2023
Q1 | $858K | Sell |
27,494
-2,930
| -10% | -$91.5K | ﹤0.01% | 2412 |
|
|
2022
Q4 | $906K | Buy |
30,424
+8,610
| +39% | +$256K | ﹤0.01% | 2392 |
|
|
2022
Q3 | $832K | Buy |
21,814
+6,631
| +44% | +$253K | ﹤0.01% | 2433 |
|
|
2022
Q2 | $828K | Sell |
15,183
-8,073
| -35% | -$440K | ﹤0.01% | 2502 |
|
|
2022
Q1 | $1.45M | Buy |
23,256
+2,840
| +14% | +$177K | ﹤0.01% | 2278 |
|
|
2021
Q4 | $2.05M | Buy |
20,416
+4,981
| +32% | +$501K | ﹤0.01% | 2137 |
|
|
2021
Q3 | $1.39M | Buy |
15,435
+577
| +4% | +$51.9K | ﹤0.01% | 2377 |
|
|
2021
Q2 | $1.37M | Buy |
14,858
+1,795
| +14% | +$166K | ﹤0.01% | 2424 |
|
|
2021
Q1 | $1.26M | Sell |
13,063
-56,169
| -81% | -$5.43M | ﹤0.01% | 2441 |
|
|
2020
Q4 | $3.61M | Buy |
69,232
+35,483
| +105% | +$1.85M | ﹤0.01% | 1742 |
|
|
2020
Q3 | $1.35M | Buy |
+33,749
| New | +$1.35M | ﹤0.01% | 2077 |
|
|
2020
Q1 | – | Sell |
-28,892
| Closed | -$373K | – | 3394 |
|
|
2019
Q4 | $373K | Buy |
+28,892
| New | +$373K | ﹤0.01% | 3062 |
|